Here’s What Is Going On With Ocugen (OCGN) Stock
Shares of Ocugen Inc. (NASDAQ: OCGN), India-based Bharat Biotech’s U.S. partner for COVID-19 vaccine Covaxin, fell 3.7% in Wednesday’s regular trading session.
Nipro To Provide Fill, Finish Services For AstraZeneca COVID-19 Shots In Japan: Reuters
Japan’s Nipro Corporation has signed an agreement to supply AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine in Japan, reports Reuters. Nipro said that the…
Moderna Sees Single-Dose COVID-19 Vaccine Launch In India In 2022
Moderna Inc (NASDAQ: MRNA) expects to launch a single-dose COVID-19 vaccine in India in 2022 and is in talks…
The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation
Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts.
Pfizer Hits Deadlock With India Over Vaccine Indemnity Issue: Reuters
Pfizer Inc (NYSE: PFE) and the Indian government are at loggerheads over a demand by the company for legal protection from any claims linked to the use of its COVID-19 vaccine, said
Ministry Of Food And Drug Safety of South Korea Authorizes Moderna’s COVID-19 Vaccine; Co Secures 40M Doses Of Vaccine
Ministry of Food and Drug Safety of South Korea (MFDS) Authorizes Moderna's COVID-19 Vaccine
South Korea has secured 40 million doses of COVID-19 Vaccine Moderna
Moderna, Inc. (NASDAQ:MRNA), a biotechnology
Japan Approves AstraZeneca’s COVID Vaccine, But Puts Use on Hold Amid Blood Clot Concern
Along with the approval of Moderna’s COVID-19 vaccine, Japan’s regulatory authority has also approved AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine, Vaxzevria for…
Moderna’s COVID-19 Vaccine Scores Emergency Use Nod In Japan
Moderna Inc (NASDAQ: MRNA) has received emergency use approval for its mRNA COVID-19 vaccine in Japan. Takeda Pharmaceutical Co Ltd (NYSE: TAK), which is…